Bioequivalence Study of Quetiapine Fumarate Tablets 300 mg Under Fasting Condition
NCT01566487
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Quetiapine fumarate
Sponsor
Dr. Reddy's Laboratories Limited